Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-Label, Multi-Center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect

NCT01041001 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT01041001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01041001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-Label, Multi-Center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect
Lead sponsor
Medipost Co Ltd.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2009
Completion date
January 31, 2011
Enrollment
104 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage injury, osteoarthritis